Events

m24sp Instrument System (sample extraction system). An in vitro diagnostic medical device (IVD) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Abbott Australasia Pty Ltd Molecular Division 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2014-RN-01010-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2014-09-18
  • 사례 국가
    Australia
  • 사례 출처
    DHTGA
  • 사례 출처 URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2014-RN-01010-1
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Abbott molecular has identified that when duplicate sample ids are used for multiple replicates of a sample, calibrator or control in the same run: some samples may not be included in the plate report; some duplicate sample ids are reassigned a unique identifier by the software and a warning message is displayed in the plate report. these issues occur if duplicate sample ids are used within a run, on the m24sp plate report. the m24sp plate report is a pdf file generated by the software for each instrument run. it provides a list of sample id’s and their processing information and error status.
  • 조치
    Abbott Molecular is advising users that to ensure proper function of the Plate Report, duplicate sample IDs should not be used on the m24sp. If two or more replicates of a sample, calibrator or control are being run, a unique sample ID should be used for each of the replicates. This action has been closed-out on 15/07/2016.

Device

m24sp Instrument System (sample extraction system). An in vitro diagnostic medical device (IVD)
  • 모델명 / 제조번호(시리얼번호)
    m24sp Instrument System (sample extraction system). An in vitro diagnostic medical device (IVD) List Number: 03N06-01 ARTG Number: 206870
  • Manufacturer
    Abbott Australasia Pty Ltd Molecular Division

Manufacturer

Abbott Australasia Pty Ltd Molecular Division
  • 제조사 모회사 (2017)
    Abbott Laboratories
  • 제조사 의견
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DHTGA